ITRMF · Iterum Therapeutics plc · Analyst Estimates
$0.03
+0.01 (+34.78%)
At close · Jul 21
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“This condition raises substantial doubt about the Company's ability to continue as a going concern for one year from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Nov 14, 2025
Market Cap
$446
Shares
44.66M
Analyst Estimates
Compare analyst forecasts for Iterum Therapeutics plc across metrics and forecast periods.
Low, average and high estimates appear together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.